ARTICLE | Clinical News
HGH-CTP regulatory update
February 18, 2013 8:00 AM UTC
Prolor said EMA granted Orphan Drug designation to hGH-CTP to treat growth hormone deficiency (GHD). The long-acting human growth hormone (hGH) combined with the company's carboxyl terminal peptide (C...